Abstract
Data on the effect of dietary arachidonic acid (AA) (20∶4n-6) on the synthesis of thromboxane and prostacyclin (PGI2) in humans are lacking. We measured the effect of 1.5 g/d (ca. 0.5 en%) of 20∶4n-6 added isocalorically to a stabilization (low-AA) diet on the excretion of 11-dehydrothromboxane B2 (11-DTXB2) and 2,3-dinor-6-oxo-PGF1α (PGI2-M). In a crossover design, 10 healthy men, living in a metabolic unit, were fed a diet (low-AA) containing 210 mg/d of 20∶4n-6 for 65 d and an identical diet (high-AA) that contained 1.5 g/d of additional 20∶4n-6 for 50 d. Three-day urine pools were collected at the end of each dietary period and analyzed for eicosanoids by gas chromatography-electron capture negative ion-tandem mass spectrometry. Mean excretion of 11-dehydrothromboxane B2 was 515±76, 493±154, and 696±144 ng/d (SD; n=10) during the acclimation (15 d) low-AA diet and high-AA diet periods, respectively (41% increase from low-AA to high-AA diet, P=0.0037); mean excretion of PGI2-M was 125±40, 151±36, and 192±55 ng/d (SD; n=10) during acclimation (15 d) low-AA and high-AA diets, respectively (27% increase from low-AA to high-AA diets; P=0.0143). Thus, both the metabolites of thromboxane and PGI2 increase on the high-AA diet. Furthermore, both indicated changes in metabolite excretion may be associated with measurable effects on several physiologically significant cellular functions, such as platelet aggregation in vivo and inflammation in response to immune challenges.
Similar content being viewed by others
Abbreviations
- 11-DTXB2 :
-
11-dehydrothromboxane B2
- GC-ECNI-MS-MS:
-
gas chromatography-electron capture negative ion-tandem mass spectrometry
- PGI2 :
-
prostacyclin
- PGI2-M:
-
2,3-dinor-6-oxo-prostaglandin F1α
- TXA2 :
-
thromboxane A2
References
Vane, J.R. (1971) Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like Drugs, Nature 231, 232–235.
Jonnalagadda, S.S., Egan, S.K., Heimbach, J.T., Harris, S.S., and Kris-Etherton, P.M. (1995) Fatty Acid Consumption Pattern of Americans: 1987–1988 USDA Nationwide Food Consumption Survey, Nutr. Res. 15, 1767–1781.
Seyberth, H.W., Oelz, O., Kennedy, T., Sweetman, B.J., Danon, A., Frölich, J.C., heimberg, M., and Oates, J.A. (1975) Increased Arachidonate in Lipids After Administration to Man: Effects on Prostaglandin Biosynthesis, Clin. Pharmacol. Ther. 18, 521–529.
Abeywardena, M.Y., McLennan, P.L., and Charnock, J.S. (1987) Long-Term Saturated Fat Supplementation in the Rat Causes an Increase in PGI2TXB2 Ratio of Platelet and Vessel Wall, Atherosclerosis 66, 181–189.
Nordøy, A., Hatcher, L., Goodnight, S., FitzGerald, G.A., and Connor, W.E. (1994) Effects of Dietary Fat Content, Saturated Fatty Acids, and Fish Oil on Eicosanoid Production and Hemostatic Parameters in Normal Men, J. Lab. Clin. Med. 123, 914–920.
Moncada, S., and Vane, J.R. (1979) Pharmacology and Endogenous roles of Prostaglandin Endoperoxides, Thromboxane A2 and Prostacyclin, Pharmacol. Rev. 30, 293–331.
Ferretti, A., Judd, J.T., Ballard-Barbash, R., Nair, P.P., Taylor, P.R., and Clevidence, B.A. (1991) Effect of Fish Oil Supplementation on the Excretion of the Major Metabolite of Prostaglandin E in Healthy Male Subjects, Lipids 26, 500–503.
Ferretti, A., Nelson, G.J., and Schmidt, P.C. (1991) Salmon-Rich Diet Inhibits Arachidonate Cyclooxygenation in Healthy Men, J. Nutr. Biochem. 2, 547–552.
Ferretti, A., Judd, J.T., Taylor, P.R., Nair, P.P., and Flanagan, V.P. (1993) Ingestion of Marine Oil Reduces Excretion of 11-Dehydrothromboxane B2, an Index of Intravascular Production of Thromboxane A2, Prostaglandins Leukotriene Essent. Fatty Acids 48, 305–308.
Ferretti, A., Flanagan, V.P., Judd, J.T., Nair, P.P., and Taylor, P.R. (1993) Fish Oil Supplementation Reduces Excretion of 2,3-Dinor-6-oxo-PGF1α and the 11-Dehydrothromboxane B2/2,3-Dinor-6-oxo-PGF1α Excretion Ratio in Adult Men, J. Nutr. Biochem. 4, 695–698.
Von Schacky, C., Fischer, S., and Weber, P.C. (1985) Long-Term Effects of Dietary Marine Ω3 Fatty Acids upon Plasma and Cellular Lipids, Platelet Function, and Eicosanoid Formation in Humans, J. Clin. Invest. 76, 1626–1631.
Fischer, S., and Weber, P.C. (1984) Prostaglandin I3 Is Formed in vivo in Man After Dietary Eicosapentaenoic Acid, Nature 307, 165–168.
Knapp, H.R., and FitzGerald, G.A. (1989) The Antihypertensive Effects of Fish Oil: A Controlled Study of Polyunsaturated Fatty Acid Supplements in Essential Hypertension, New Engl. J. Med. 320, 1037–1043.
Abeywardena, M.Y., Fischer, S., Schweer, H., and Charnock, J.S., (1989) In Vivo Formation of Metabolites of Prostaglandins I2 and I3 in the Marmoset Monkey (Callithrix jacchus) Following Dietary Supplementation with Tuna Fish Oil, Biochim. Biophys. Acta 1003, 161–166 (1989).
Knapp, H.R., and Salem, N., Jr. (1989) Formation of PGI3 in the Rat During Dietary Fish Oil Supplementation, Prostaglandins 38, 509–521.
Li, B., Birdwell, C., and Whelan, J. (1994) Antithetic Relationship of Dietary Arachidonic Acid and Eicosapentaenoic Acid on Eicosanoid Production in vivo, J. Lipid Res. 35, 1869–1877.
Whelan, J., Surette, M.E., Stiles, B.L., Chiu, C.H., and Claycombe, K. (1995) Dietary Arachidonic Acid Abrogates the Effects of Dietary n-3 Polyunsaturated Fatty Acids, INFORM 6, 464 (Abstract).
Recommended Dietary Allowances (1989) Committee on Dietary Allowances, Food and Nutrition Board, Commission on Life Sciences, National Research Council, 10th edn., National Academy Press, Washington, D.C.
U.S. Department of Agriculture (1992) Handbook 8, The Composition of Foods, USDA, ARS, Nutrient Data Laboratory, Riverdale, MD.
Nelson, G.J., Kelley, D.S., Emken, E.A., Phinney, S.D., Kyle, D., and Ferretti, A. (1997) A Human Dietary Arachidonic Acid Supplementation Study Conducted in a Metabolic Research Unit: Rationale and Design, Lipids 32, 415–420.
Ferretti, A., Flanagan, V.P., and Maida, E.J. (1992) GC/MS/MS Quantification of 11-Dehydrothromboxane B2 in Human Urine, Prostaglandins Leukotrienes Essent. Fatty Acids 46, 271–275.
Ferretti, A., and Flanagan, V.P. (1993) Assay of Urinary 2,3-Dinor-6-oxo-PGF1α by Gas Chromatography-Tandem Mass Spectrometry, J. Chromatogr. (B) 622, 109–115.
Nelson, G.J., Schmidt, P.C., Bartolini, G., Kelley, D.S., Phinney, S.D., and Kyle, D (1997) The Effect of Dietary Arachidonic Acid on Plasma Lipoprotein Distributions, Apoproteins, Blood Lipid Levels, and Tissue Fatty Acid Composition in Humans, Lipids 32, 427–433.
Nelson, G.J., Schmidt, P.C., Bartolini, G., Kelley, D.S., and Kyle, D. (1997) The Effect of Dietary Arachidonic Acid on Platelet Function, Platelet Fatty Acid Composition and Blood Coagulation in Humans, Lipids 32, 421–425.
Pace-Asciak, C., and Wolfe, L.S. (1971) A Novel Prostaglandin Derivative Formed from Arachidonic Acid by Rat Stomach Homogenates, Biochemistry 10, 3657–3664.
Mann, N.J., Warrick, G.E., O’Dea, K., Knapp, H.R., and Sinclair, A.J. (1994) The Effect of Linoleic, Arachidonic, and Eicosapentaenoic Acid Supplementation on Prostacyclin Production in Rats, Lipids 29, 157–162.
Sanigorski, A.J., O’Dea, K., and Sinclair, A.J. (1994) n-3 Fatty Acids Reduce in vitro Thromboxane Production While Having Little Effect on in vitro Prostacyclin Production in the Rat, Prostaglandins Leukotrienes Essent. Fatty Acids 50, 223–228.
Sanigorski, A.J., Sinclair, A.J., and Hamazaki, T. (1996) Platelet and Aorta Arachidonic and Eicosapentaenoic Acid Levels and Eicosanoid Production in Rats Fed High Fat Diets, Lipids 31:729–735.
Author information
Authors and Affiliations
About this article
Cite this article
Ferretti, A., Nelson, G.J., Schmidt, P.C. et al. Increased dietary arachidonic acid enhances the synthesis of vasoactive eicosanoids in humans. Lipids 32, 435–439 (1997). https://doi.org/10.1007/s11745-997-0057-5
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11745-997-0057-5